Letter by Pirson et al Regarding Article, "Results From DEFUSE 3 Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome"

F. Anne V. Pirson; Wim H. van Zwam; Robert J. van Oostenbrugge

doi:10.1161/STROKEAHA.119.025419

Letter by Pirson et al Regarding Article, "Results From DEFUSE 3 Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome"

F. Anne V. Pirson^*, Wim H. van Zwam, Robert J. van Oostenbrugge

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

7 Downloads (Pure)

Original language	English
Pages (from-to)	E164-E164
Number of pages	1
Journal	Stroke
Volume	50
Issue number	6
DOIs	https://doi.org/10.1161/STROKEAHA.119.025419
Publication status	Published - Jun 2019

Access to Document

10.1161/STROKEAHA.119.025419

Full TextFinal published version, 35.7 KBLicence: Taverne

Cite this

@article{87de097186e446f98f0153474a69cd76,

title = "Letter by Pirson et al Regarding Article, {"}Results From DEFUSE 3 Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome{"}",

author = "Pirson, {F. Anne V.} and {van Zwam}, {Wim H.} and {van Oostenbrugge}, {Robert J.}",

note = "Funding Information: MR CLEAN LATE (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands for Late Arrivals) is subsidized by Netherlands Cardiovascular Research Initiative (CVON2015-01: CONTRAST), an initiative of the Dutch Heart Foundation, by the Brain Foundation Netherlands (HA2015.01.06), and by Health Holland, Top Sector Life Sciences & Health (LSHM17016), Stryker, Ceronovus, ZonMW, and of Medtronic.",

year = "2019",

month = jun,

doi = "10.1161/STROKEAHA.119.025419",

language = "English",

volume = "50",

pages = "E164--E164",

journal = "Stroke",

issn = "0039-2499",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "6",

}

Letter by Pirson et al Regarding Article, "Results From DEFUSE 3 Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome". / Pirson, F. Anne V.; van Zwam, Wim H.; van Oostenbrugge, Robert J.
In: Stroke, Vol. 50, No. 6, 06.2019, p. E164-E164.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Letter by Pirson et al Regarding Article, "Results From DEFUSE 3 Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome"

AU - Pirson, F. Anne V.

AU - van Zwam, Wim H.

AU - van Oostenbrugge, Robert J.

N1 - Funding Information: MR CLEAN LATE (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands for Late Arrivals) is subsidized by Netherlands Cardiovascular Research Initiative (CVON2015-01: CONTRAST), an initiative of the Dutch Heart Foundation, by the Brain Foundation Netherlands (HA2015.01.06), and by Health Holland, Top Sector Life Sciences & Health (LSHM17016), Stryker, Ceronovus, ZonMW, and of Medtronic.

PY - 2019/6

Y1 - 2019/6

U2 - 10.1161/STROKEAHA.119.025419

DO - 10.1161/STROKEAHA.119.025419

M3 - Comment/Letter to the editor

C2 - 31084329

SN - 0039-2499

VL - 50

SP - E164-E164

JO - Stroke

JF - Stroke

IS - 6

ER -